These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2825840

  • 1. [Long-term enhancement of morphine hypalgesia as a result of periodic blockade of opiate receptors using naloxone].
    Kiiatkin EA, Zhukov VN.
    Biull Eksp Biol Med; 1987 Dec; 104(12):692-5. PubMed ID: 2825840
    [Abstract] [Full Text] [Related]

  • 2. Substance P-induced long-term blockade of spinal adrenergic analgesia: reversal by morphine and naloxone.
    Nance PW, Sawynok J.
    J Pharmacol Exp Ther; 1987 Mar; 240(3):972-7. PubMed ID: 2435888
    [Abstract] [Full Text] [Related]

  • 3. Determinants of the analgesic action of opiates.
    Kiyatkin EA, Zhukov VN.
    Acta Physiol Pharmacol Bulg; 1988 Mar; 14(2):10-7. PubMed ID: 2906205
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of morphine analgesia by lithium: role of peripheral and central opioid receptors.
    Johnston IN, Westbrook RF.
    Behav Brain Res; 2004 May 05; 151(1-2):151-8. PubMed ID: 15084430
    [Abstract] [Full Text] [Related]

  • 5. [The enkephalinase mechanisms of the resistance and tolerance to the analgesic effect of morphine in rats. Differences in the effects of naloxone in morphine-sensitive, morphine-resistant and morphine-tolerant rats].
    Kaliuzhnyĭ LV, Kozlov AIu, Litvinova SV.
    Biull Eksp Biol Med; 1993 Jul 05; 116(7):6-9. PubMed ID: 8400186
    [Abstract] [Full Text] [Related]

  • 6. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
    Pasternak GW, Childers SR, Snyder SH.
    J Pharmacol Exp Ther; 1980 Sep 05; 214(3):455-62. PubMed ID: 6105201
    [Abstract] [Full Text] [Related]

  • 7. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation.
    Tempel A, Gardner EL, Zukin RS.
    J Pharmacol Exp Ther; 1985 Feb 05; 232(2):439-44. PubMed ID: 2982011
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat.
    Winters WD, Hance AJ, Cadd GG, Quam DD, Benthuysen JL.
    J Pharmacol Exp Ther; 1988 Jan 05; 244(1):51-7. PubMed ID: 3336011
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhancement of naloxone-induced analgesia by pretreatment with morphine.
    Cappell H, Poulos CX, Lê AD.
    Pharmacol Biochem Behav; 1989 Oct 05; 34(2):425-7. PubMed ID: 2560204
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
    Tseng LF, Fujimoto JM.
    J Pharmacol Exp Ther; 1985 Jan 05; 232(1):74-9. PubMed ID: 3155550
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.